Applications of Stem Cells in Drug Discovery - Market Research Reports

Printer Friendly

Printed from http://www.researchandmarkets.com/reports/314592

Applications of Stem Cells in Drug Discovery

Description:

Stem cells are unspecialized cells that can differentiate into numerous types of specialized cells with specific functions. Diseases and disorders that might benefit from stem-cell research include Parkinson’s, Alzheimer’s, diabetes, cancer, heart disease, spinal cord injury, and multiple sclerosis, as well as organ transplantation and wound treatment. Stem cells are also a valuable source of material in drug discovery, high-content screening assays, and toxicology studies.

In this report, we discuss the study of both undifferentiated stem cells and adult stem cells, the use of stem-cell biology to elucidate the pathways and mechanisms involved in different diseases, ongoing research to develop methods of using stem cells to replace disease-damaged cells, stem-cell-based drug discovery platforms, the use of stem cells in drug screening and toxicology, and the outlook for stem-cell-based drug discovery. We also profile companies and consortia involved in stem-cell research and examine the legal issues surrounding the field.

Business Implications
- The development of stem cells for therapeutic purposes, including cell therapy and regenerative medicine, is emerging as a major field of pharmaceutical research. Stem-cell technology is also making inroads in drug discovery. This technology offers great potential for understanding disease mechanisms and identifying targets. Pharmaceutical companies that successfully integrate stem-cell technologies will have a competitive advantage.
- Stem cells have numerous applications in drug discovery. They are important for understanding differentiation pathways, for identifying factors needed to manipulate cell lineages, for improving screening assays, and for identifying disease targets. The production of stem-cell-derived human hepatocytes will have an immediate impact on toxicology and metabolism studies.
- Dozens of stem-cell companies are competing with one another and seeking collaborations with big pharmaceutical companies. Although the technology in these companies is still primarily in the research phase, some groups have demonstrated proof-of-concept for stem-cell technologies in animal models. Those companies that ultimately control the rights to stem cells and their uses will become dominant players. Companies that conduct stem-cell-based drug discovery and product development will achieve the greatest value.
- An important new approach in the stem-cell field is the creation of multidisciplinary research consortia of academic, medical, government, and industry partners. Although consortia could foster major advances, whether they will be able to translate basic research into the commercial arena is unclear. If successful, the consortia members will gain a major advantage in developing and applying stem-cell technology.

Contents:

Introduction
Overview of Stem Cells
Legal Issues
Stem-Cell Development
Adult Stem-Cell Research
Target Identification: Manipulating Differentiation Pathways
Stem-Cell Therapy vs. Cell Protection
Stem Cells in Cellular Assays for Screening
Stem-Cell-Based Drug Discovery Platforms
Drug Screening and Toxicology
Stem-Cell-Based Consortia
Outlook for Stem-Cell-Based Drug Discovery
Figure 1. Embyonic Stem Cells (ESCs) Differentiate into Any Cell Type
Table 1. Available Human Embryonic Stem-Cell Lines Eligible for Use with U.S. Federal Funding
Table 2. Select Companies Active in the Development and Application of Stem Cells
Table 3. Select Consortia and Institutes Involved in Stem-Cell Research

Companies Mentioned

- Aastrom Biosciences - Advanced Cell Technology - AmCyte - Arteriocyte - Athersys - BeFutur Biotechnologies - Cellartis - Cellerant Therapeutics - CNAssays - CyThera - Develogen - Epiontis

Ordering:

Order Online - visit http://www.researchandmarkets.com/reports/314592

Order by Fax - using the order form below

Order By Post - print the order form below and send to

Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.

Page 1 of 2
Printed 05/09/2008 15:36:03

Fax Order Form

To place an order via fax simply print this form, fill in the information below and fax the completed form to the number at the bottom of this page. If you have any questions please email help@researchandmarkets.com

Order information

Please verify that the product information is correct and select the format you require.


Product Name:
Applications of Stem Cells in Drug Discovery
Web Address:
http://www.researchandmarkets.com/reports/314592
Office Code:
OCHHGKIKPUS

Report formats

Please enter the quantity of the report format you require.

	Format	Quantity	Price
	Electronic (PDF) - Single User		€695.00

Contact information

Please enter all the information below in BLOCK CAPITALS.


	First Name:	Last Name:
	Email Address:
	Job Title:
	Organisation:
	Address:
	City:
	Postal/Zip Code:
	Country:
	Phone Number:
	Fax Number:

Please fax this form to:
(646) 607-1907 or (646) 964-6609 - From USA
+353 1 481 1716 or +353 1 653 1571 - From Rest of World

Page 2 of 2
Printed 05/09/2008 15:36:03

Payment information

Please indicate the payment method you would like to use by selecting the appropriate box.

Pay by Credit Card:

	American Express
	Diners Club
	Master Card
	Visa


Cardholder Name:

Expiry Date:	/

Card Number:

CVV Security Code:

Issue Date:	/ (Diners Club only)

Pay by Check:

Please post the check, accompanied by this form, to:

Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.

Pay by Wire Transfer:

Please transfer funds to:


Account number:	83313083
Sort code:	98-53-30
Swift code:	ULSBIE2D
IBAN number:	IE78ULSB98533083313083
Bank Address:	Ulster Bank, 27-35 Main St, Blackrock, Co. Dublin, Ireland.

If you have a Marketing Code please enter it below:
	Marketing Code:

Please note that by ordering from Research and Markets you are agreeing to our Terms and Conditions at http://www.researchandmarkets.com/info/terms.asp

Please fax this form to:
(646) 607-1907 or (646) 964-6609 - From USA
+353 1 481 1716 or +353 1 653 1571 - From Rest of World